In this study, the main efficacy comparisons are for each of the FLU-v groups to placebo. The study will also compare the two FLU-v dosing arms but will only have power to detect a significant difference in Mild to Moderate Influenza Disease (MMID) rates between the FLU-v groups and placebo and not against each other.